Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00426569
Other study ID # SHEBA-07-4534-AY-CTIL
Secondary ID
Status Completed
Phase N/A
First received January 23, 2007
Last updated May 22, 2015
Start date February 2007
Est. completion date May 2015

Study information

Verified date May 2015
Source Sheba Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Observational

Clinical Trial Summary

The purpose of this study is to check if bacterial and fungal flora exists in healthy paranasal sinuses, and whether it is identical to the flora of nasal cavity.

We plan to harvest tiny examples of maxillary sinus and nasal mucosa for tissue cultures during the orthognathic procedures involving maxillary remodeling.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date May 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Necessity of maxillary sinus opening during orthognathic surgery

- Negative history of chronic rhinitis or chronic sinusitis

- Informed concent

Exclusion Criteria:

- Recent(1 month or less before the operation) event of acute sinusitis or other disease leading to nasal discharge

- Recent(1 month or less before the operation) antibacterial or antifungal parenteral treatment

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Sheba Medical Center Tel Hashomer

Sponsors (1)

Lead Sponsor Collaborator
Sheba Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary presence of bacteria in normal paranasal sinuses at time of orthgnatic surgery No
See also
  Status Clinical Trial Phase
Recruiting NCT05027633 - Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) Phase 2